A pancreatic cancer expert on why Revolution Medicines’ study could ‘open up a new era’ of treatment - statnews.com

"I do think it's a revolution," said Paul Oberstein of NYU Langone's Perlmutter Cancer Center.

You will be redirected in 10 seconds.